Vinorelbine and ifosfamide for unresectable non-small cell lung cancer.
- 1 August 1997
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 18 (1) , 95-100
- https://doi.org/10.1016/s0169-5002(97)00044-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Chemotherapy of stage IIIB and IV non-small-cell lung cancerAnnals of Oncology, 1995
- Chemotherapy in non-small cell lung cancerAnnals of Oncology, 1995
- A data-based meta-analysis of randomised trials of chemotherapy versus best supportive care (BSC) in advanced non-small cell lung cancer (NSCLC)Lung Cancer, 1994
- Treatment of the elderly small cell lung cancer patientLung Cancer, 1994
- Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.Journal of Clinical Oncology, 1994
- Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trialAnnals of Oncology, 1994
- Polychemotherapy in advanced non small cell lung cancer: a meta-analysisThe Lancet, 1993
- Mitomycin, Ifosfamide, and Cisplatin in Non-Small Cell Lung CancerOncology, 1993
- Phase I–II study of vinorelbine (Navelbine®) plus cisplatin in advanced non-small cell lung cancerEuropean Journal Of Cancer, 1992
- A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 1991